One of the biggest events for investors last week was the new additions to the Russell 3000 Index. The inclusion in the index means several ETFs have to add shares of the stocks as part of the rebalancing efforts.
Piper Sandler analyst Alexander Potter initiates coverage on Shift Technologies (NASDAQ:SFT) with a Overweight rating and announces Price Target of $14.
Gainers
Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 72% to close at $10.25 on Monday after the company reported the FDA approval of IND application for CpG-STAT3siRNA, its distinctive immuno-oncology RNA therapy for the treatment of multiple cancers.
On CNBC's "Mad Money Lightning Round," Jim Cramer said Hyliion Holdings Corp (NYSE: HYLN) is doing exactly what it should do so longer-term it should pan out.